Becker's Healthcare January 2, 2025
Alexandra Murphy

The FDA has finalized a rule that establishes requirements for nonprescription drug products with additional conditions for nonprescription use (ACNU).

Set to take effect Jan. 27, 2025, the rule aims to expand access to nonprescription drugs while ensuring consumers can self-select and use them appropriately.

Here are five notes:

  1. The FDA’s final rule defines a nonprescription drug product with an ACNU as one that could be marketed without a prescription if the manufacturer implements an additional condition to ensure appropriate self-selection or actual use by consumers without the supervision of a healthcare provider.
  2. The rule aims to “increase options for applicants to develop and market safe and effective nonprescription drug products,”...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies
Supporting the Development of Drugs for Rare Diseases — The Importance of Regulatory Transparency
Opinion: To fight for those with rare diseases, Trump must reform and modernize the FDA thoughtfully
5 Rare Diseases That Now Have Their First FDA-Approved Treatments
This Bill Could Make It Legal for AI to Prescribe Medicine
STAT+: Trump’s FDA navigates layoffs, exits, and a new hire

Share This Article